A Norwegian multicenter trial assessing effectiveness of targeting biosimilar infliximab treatment by therapeutic drug monitoring -The NOR-DRUM study
- Prosjektnummer
- 2016061
- Ansvarlig person
- Tore Kristian Kvien
- Institusjon
- Diakonhjemmet Sykehus AS
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Inflammatory and Immune System, Musculoskeletal, Oral and Gastrointestinal, Skin
- Forskningsaktivitet
- 6. Treatment Evaluation
nei
nei
nei
NEI
Nei
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA 2021 12 21;326(23):2375-2384.
PMID: 34932077
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA 2021 05 04;325(17):1744-1754.
PMID: 33944876
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.
JAMA 2021 09 21;326(11):1069-1070.
PMID: 34546304
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
Trials 2020 Jan 06;21(1):13. Epub 2020 jan 6
PMID: 31907007
- Marthe Kirkesæth Brun Doktorgradsstipendiat (annen finansiering)
- Tore Kristian Kvien Prosjektleder
- Ragnar Akre-Aas Brukerrepresentant
- Bjørn Gulbrandsen Brukerrepresentant
- Jon Hagfors Brukerrepresentant
- Johanna Gehin Forsker (annen finansiering)
- Joseph Andrew Sexton Forsker (annen finansiering)
- Inge Christoffer Olsen Forsker (annen finansiering)
- Nils Bolstad Forsker (annen finansiering)
- Cato Mørk Forsker (annen finansiering)
- Jørgen Jahnsen Forsker (annen finansiering)
- Øystein Sandanger Forsker (annen finansiering)
- Kristin Kaasen Jørgensen Forsker (annen finansiering)
- Guro Løvik Goll Postdoktorstipendiat (annen finansiering)
- Espen Haavardsholm Prosjektleder
- Silje Watterdal Syversen Postdoktorstipendiat (finansiert av denne bevilgning)
- Espen Andre Haavardsholm Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport